Thursday, January 10, 2008 - Page updated at 12:00 AM
E-mail article
Print view Share:
Digg
Newsvine
Omeros plans $115 million IPO
Seattle Times staff
Seattle-based biopharmaceutical company Omeros has filed for an initial public offering of stock, aiming to raise as much as $115 million.
It is the first new IPO filing from a local company this year, and follows a rocky 2007 during which more initial offerings were withdrawn than were completed.
The company, founded in 1994, has no product revenue and no products approved for marketing.
It is developing compounds for inflammation and disorders of the central nervous system, specifically low-dosage proprietary combinations of therapeutic drugs that are delivered during surgery.
Its most advanced product candidates are targeted at arthroscopic, ophthalmological and urological surgery.
Proceeds of the IPO would be used, in part, to complete Phase 3 clinical trials of its leading candidate.
Omeros has spent $72 million since its inception, and had $27 million in available cash as of Sept. 30, according to the company's preliminary filing with the Securities and Exchange Commission.
The company did not give an estimated price or number of shares for its proposed offering, which is being underwritten by Deutsche Bank Securities, Pacific Growth Equities, Leerink Swann and Needham & Company.
Copyright © 2008 The Seattle Times Company
Dow dives 508 points despite Fed moves
Bernanke: We could face prolonged economic pain
Alaska Air stock sinks on profit warning
Boeing exec warns about state becoming known as a "strike zone"
NEW - 07:10 PM
Former WaMu execs raising money for workers losing stock, jobs

Best Northwest Employers
Vote for your favorite Northwest employers in the 2008 NWjobs People's Picks contest. Vote now.
- Kennewick reservist faces threats over landscaping
- Revisiting McCain's Keating 5 history | Close-up
- Boeing CEO in no hurry to settle strike
- Face the grim reality of the 2008 Seahawks | Steve Kelley
- The measure of Palin's inexperience: She's not ready for her close-up
- UW's use of freshmen has some fans seeing red
- Dow closes below 10,000 amid global sell-off
- Countrywide suit settled; homeowners to get aid
- Obama's allies warn GOP: Lay off attacks
- Positions harden in Boeing strike; McNerney, unions spar over outsourcing
- Revisiting McCain's Keating 5 history | Close-up
- Graduates drowning in debt from high cost of college
- Countrywide suit settled; homeowners to get aid
- King County home prices slide again, but more people are buying
- Boeing CEO in no hurry to settle strike
- With no way out of trouble, more students likely to default
- Oregon Labrador headed to DockDogs National Championships
- Positions harden in Boeing strike; McNerney, unions spar over outsourcing
- Seattle's first parish centered on traditional Latin Mass
- Drug companies: No cold medicines for kids under 4
